Author Question: What is a difficulty in relying on referent values or cutoffs in converting a numerical test results ... (Read 53 times)

Evvie72

  • Hero Member
  • *****
  • Posts: 519
What is a difficulty in relying on referent values or cutoffs in converting a numerical test results into a yes-or-no clinical diagnosis?
 
  A) Test results can fall beyond the cutoff values, leaving the diagnostic question unanswered.
  B) The cutoff value is patient-specific and must be calculated for each individual patient.
  C) The value considered to be the cutoff is variable depending on the prescribing physician.
  D) There is a range of test result values that are shared between those with and without the condition.

Question 2

Which of the following variables has a significant effect on the predictive value of a test?
 
  A) The doctor diagnosing the condition
  B) The prevalence of the condition
  C) The severity of the condition
  D) The volume of the patient's sample tested



mmj22343

  • Sr. Member
  • ****
  • Posts: 297
Answer to Question 1

D

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

For a complete list of videos, visit our video library